Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine if trabecular or cortical volumetric bone
mineral density (vBMD) change over time in postmenopausal breast cancer patients who are
prescribed Anastrozole, as measured by pQCT at the proximal and distal radius and tibia.